chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hip Pain in my right side started the week after my 3rd Moderna COVID19 vaccine dose which was the booster.  Both previous doses were Moderna as well and with all of them I didn't have much reaction except arm pain.  Hip was diagnosed as a labrum tear and arthritis but I hadn't had any pain prior to this.  Going to PT for this issue.  Pain from my hip is limiting my mobility.  Back pain started next in early February 2022 and developed into pain and tingling in my feet.  Lumbar MRI didn't show any injury and waiting to have another on the rest of the spine since I have tingling all over my body.   B12 was found to be very low and taking supplements but still having the sensations.   Going to PT for this issue.  Started to have tingling and numbness in both hands after waking up with this starting in March of 2022.  This has continued and the doctors don't know if it is in the neck or in the arms.  Never had anything like this prior to the start of this a couple of months ago.  Having knee pain in both knees especially the left which I had 3 torn ligaments repaired in May 2016.  Have been active since this injury but now the pain in it and my right are limiting my mobility.  All joints are starting to click and crack when moving them at times which is all new to me.  Prior to December 2021 only my left ankle consistently did this because of multiple injuries to that joint.  Now all from my neck down including my back clicks and cracks multiple times a day.
After vaccination patient developed expiratory wheezing's Treated with Decadron 4 mg IM x 1
Sick 4 days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick 4 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick 4 days). At the time of the report, ILLNESS (Sick 4 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by the reporter.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-046640 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-046640:Reporter's case
after the 3rd dose, both of them experiences soreness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: unknown), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE, Lot number: unknown), for COVID-19 immunization, reaction(s): "they got the first 2 doses 2 weeks apart". The following information was reported: PAIN (non-serious), outcome "recovered", described as "after the 3rd dose, both of them experiences soreness".  Additional information: It was reported that the patient and his wife had both the series of Pfizer injections where they got the first 2 doses 2 weeks apart and then got the 3rd, 4th and 5th booster, reporter stated they had a total of 5 injections. Patient stated after the 3rd dose, both of them experienced soreness that went away after 3 or 4 days. Patient stated after the 4th dose in the 4th month of this year (Apr2022), about 10 to14 days after it made his wife's skin got brown and they thought it was bruising. Patient stated her skin was dark and it started making like an indentation where it kept sinking where the injection site was. Patient stated the indentation was then around the size of a nickel that was dark and had been getting deeper in indentation. Patient stated it had gotten deeper over the last month. Patient stated when they went to get their 5th injection, the pharmacist said she had never seen that before.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201368860 same patient and drug, different dose and event;
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) on or about 05-FEB-2009 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 08-MAY-2017, the patient was treated for the onset of a severe vesicular eruption accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. On or about 09-JUN-2017, the patient sought subsequent treatment from a physician for ongoing and worsening symptoms of shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
About 2 to 3 hours after vaccination, patient experienced pain in left arm at site of injection. The next day patient had muscle aches/pains, headache, fu-like symptoms. When she went to bed that night she had "restless" legs.  Pt said she took ibuprofen about every 4 hours and began to feel better. Today she feels much better but is tired and weak. No fever.
Patient received Pfizer BioNTech EUA Covid 19 Vaccine at 2:47pm.  At 3:02 pm he reported tingling tongue from back sides around to front edges.  Vitals: 3:05 133/86, HR 82 O2 94%, 3:10 133/87, HR81 O2 95%, 3:16 124/83 HR78 O294%, 3:21 112/74 HR77 O2 95%, 3:32 129/84, HR80 O2 93%.  By 3:32 patient reported tingling had receded and was released home with instructions to call MD or ER if symptoms should recur.  Patient has history of daily smoking and takes 81mg of aspirin and multivitamins daily.
Within one minute of receiving vaccine, the patient became pale, stated that he felt dizzy and fainted.  Patient regained consciousness within one minute.  Upon regaining consciousness, patient reported feeling lightheaded and dizzy but was oriented to person, place and time.  Skin was warm and dry but pale in color.  After regaining consciousness, patient also stated that he has a history of fainting 5-6 years ago after receiving an influenza vaccination. (During screening questions, patient denied having any reactions to vaccines in the past) Patient independently moved from a chair to a laying down position on a cot and expressed an improvement in how he was feeling.  Vital signs taken after event as recorded below.  When asked patient stated that he does recall times when he thinks he may have been hypoglycemic in the past. Patient also states that he has been very nervous about receiving injections throughout his life.  EMS called and assessed patient at the vaccination clinic site.  Patient drank a 10 oz bottle of orange juice prior to EMS arriving and when EMS staff obtained his blood sugar the result was 97.  EMS stated that patient was stable and all vital signs were stable.  Patients skin color improved to pink.  Patients wife was called by patient and she provided transportation home for patient.  Prior to leaving the vaccination clinic, patient was walking around for several minutes and denied any feelings of being lightheaded or dizzy.  VITALS SIGNS: 5:06pm: Heart rate: 50, Oxygen Saturation: 99% on room air 5:15 pm: Blood pressure: 100/78 ; Heart rate: 50; oxygen saturation 99% on room air. 5:20pm: Blood pressure 98/76 Heart rate:52; oxygen saturation 96% on room air. 5:34 pm: Blood pressure 92/68 Heart rate: 53 oxygen saturation 97% on room air. Vital signs taken by EMS staff were not recorded by public health nursing staff.
Headache, Myalgia, Arthralgia, Fever & NauseaVomiting Narrative:  Symptoms started day after shot, subsiding the following day  Other Relevant History:
This spontaneous report as received from a health professional refers to a 13 month old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 30-NOV-2015 , the patient was vaccinated with an improperly stored dose of VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
First day started with 103 degree fever, shivering and muscle pain. Getting worse with cough and lethargy continues for 5 days, on 5th day severe asthma attack, seen in urgent care and transported to ER where he received iv steroids to stabilize and x-ray  found bronchitis, he also had a seizure at home and wet the bed.  During this I did stay in touch with pediatrician almost daily. On day 5, my son was coughing so bad that he was vomiting and could not catch a breath.
Patient waited 50 min after receiving HEP A vaccine. Patient experienced syncope while driving, was in an accident, and was taken to the ER.
Starting evening of receiving vaccination SX included: lightheadedness, headache, diarrhea, N/V, fever, swollen/stiffness with numbness to fingers, stiff neck. SX lasted approx 48 hrs was evaluated by HCP 10-3-13 who diagnosed her with systemic RXN to Hep B vaccine. No allergic RXN. Given Ondansetron IM for nausea and APAP for fever/aches/pains.
I had a bad cold, cough, nasal congestion, headache, chills, and exhaustion. I had a fever of 102 degrees for 2 days. It seem like I had a cough and post nasal drip for a while after I had quarantined for 10 days. I still had a dry cough too. Covid 3rd Dose (1/20/2022): Lot Number: FL3197.
Information has been received from a pharmacist concerning a patient who on an unspecified date developed a zoster rash. The patient administered doses of zoster vaccine live (Oka/Merck) at a clinic. No information was provided. Follow up information received from the pharmacist confirmed that a health care worker who administers the vaccine came down with a confirmed case of zoster. The worker was not previously vaccinated. Additional information is not expected. This is one of several reports from the same source.
Pt reported feeling sick like she has the flu, redness and blotchy arm at site of injection on, soreness, hard to the touch, felt warm and was itchy all over and felt sick for 5 days. Patient reported taking some tylenol for her fever and some benadryl for the itching.
Initial report was received from a health care professional on 29 February 2012. A male patient had received an injection of ADACEL, sanofi pasteur Ltd. lot number C3058AA (route and site not reported) on 14 March 2009 and approximately 3 years later, the patient tested positive for Pertussis. No further information was available at the time of the report. The patient's outcome was not reported. Documents held by sender: None.
no further AE information provided; administration of improperly stored vaccines; This spontaneous report as received from a certified medical assistant refers to a 14-month-old patient of unknown gender. Information regarding the patient's pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant therapy was not reported.  On 31-AUG-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (dose and route of administration were not reported, lot # T002848, expiration date 23-JAN-2022), for prophylaxis. The vaccine was reconstituted with a sterile diluent (STERILE DILUENT). Previously, the vaccine had experienced temperature excursion from 6 Fahrenheit degrees to 14 Fahrenheit degrees (8.47 Fahrenheit degrees) for 30 minutes. The current temperature excursion was from 4 Fahrenheit degrees to 14 Fahrenheit degrees (10.56 Fahrenheit degrees) for 50 minutes. Digital data logger was used. No adverse event was reported.
Patient reported being diagnosed with Polymyalgia Rheumatica. Signs started roughly 10 days after vaccination. Patient reported bilateral muscle/joint pain above the hips along with headaches. Patient has been treated with steroids (Prednisone).  As of today's date (3-24-18) patient reported that there is no longer the muscle and joint pain, but mild headaches continue.
This spontaneous report was received from a Medical Assistant referring to multiple unspecified patients of unknown age and gender. Information about patients' medical history, concurrent conditions and concomitant medication were not reported. On unspecified dates, the patients received an improperly stored dose of PROQUAD (lot # M033908 expiration date: 16-JAN-2018) (dose and route of administration were not reported) for prophylaxis. No adverse effects reported. Temperature excursion details: Temperature: Between 5 °F and 14 °F; highest temperature: 5.46 °F Time frame: 55 hours Previous temperature excursion? Yes, 13.12 °F for 42 hours and 55 minutes. A data logger was used. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA001822.
Patient had received full course (2 shots) in 2019. No need for new series.  There was no physical adverse event. Patients insurnace plan allowed for a paid claim so the assumption at the time was she did not receive the vaccine.
Came to emergency room with generalized weakness and memory deficit. Patient was admitted with COVID 19 pneumonia without hypoxemic respiratory failure.  Patient was treated with vitamin-C, zinc, Lovenox and oral steroids.  He remained off supplemental oxygen. Found to be very deconditioned and was discharged to SNF.
Right arm was very sore after receiving shot. Took some Tylenol and went to bed at approximately 10:00pm. Did not sleep well as my arm hurt. About 4:00 am I woke up shivering uncontrollably, had a horrible headache and could not move right arm at all.  Husband brought me another Tylenol and some water. After a while I dozed off and woke up approximately 6:30. I have had a headache all morning but my arm is not as bad as it was earlier.
Pt. requested a regular Flu adult dose and pt. received a Flu Hi dose via intramuscular, left deltoid. Pt. denied any symptoms or side effects at end of observation time period at 4:30PM.  Pt. also received a COVID vaccine with the Flu vaccine. Followed-up on pt. on 12/08/2021 at 8:45AM via phone by RN. Pt stated  she has been in bed since Monday with headaches, fever of 100.9 F, chills, and body aches. Pt. reported fever has resolved, but headaches and body aches persists.
This spontaneous report was received from a registered nurse, and refers to a 30 year old female patient with allergy to BACTRIM (hives and shortness of breath), allergy to Acyclovir (ataxia and confusion), allergy to PEG-asparaginase (anaphylaxis) and allergy to Erwinia L-Asparaginase (anaphylaxis). The patient had no concomitant medications and no medical history. On an unspecified date in 2008, the patient was vaccinated with the first dose of GARDASIL, intramuscularly, to prevent human papillomavirus (dose, frequency, lot number and expiration date were not provided). Furthermore, it was also reported that between an unspecified date in 2008 to an unspecified date in 2009 the patient received the 2 doses of GARDASIL intramuscularly (dose, frequency, lot number and expiration date were not provided), also to prevent human papillomavirus. On 06-SEP-2017, the patient was diagnosed with leukemia. As a result, the patient was sought for medical attention and hospitalized for 4 weeks. Additionally, it was reported that on an unknown date, the patient underwent a complete blood count (CBC) and a bone marrow aspiration, however the results were not provided. Moreover, on 02-FEB-2018, the patient was again hospitalized for 4 weeks and was treated with a stem cell transplant. At the time of reporting, the outcome of leukemia was reported as resolving. The causal relationship between GARDASIL and leukemia was not provided. Upon internal review, the event leukemia was determined to be medically significant.
The patient was given SHINGRIX vaccine on 8/17/2018 afternoon. Presented to Hospital ED, where I saw her for fever, chills and Supraventricular Tachycardia. The SVT was new, required conversion with adenosine IV. She was discharged home with no ill effects but was PSVT not listed as a side effect in UpToDate (but chills, aches, fever were). Just wanted to report it in case there is some other reports.
This spontaneous report was received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. Pertinent medical history, concurrent conditions and concomitant therapies were not reported. On an unknown dates, the patients were vaccinated with doses of ROTATEQ (lot number and expiration dates not reported) for prophylaxis, which were improperly stored at >46°F but < 77°F for 15 minutes. No adverse effects were reported. There were no previous temperature excursions and call was done because of a data logger. No further information was provided. This is one of 5 reports from the same source. Additional information has been requested. Sender's Comments: US-009507513-1701USA009556: US-009507513-1701USA009570: US-009507513-1701USA009571: US-009507513-1701USA009572.
Developed COVID.  Tested positive on 06/17/2022.  Received Paxlovid as a result of contacting our physician.  Symptoms were fatigue, headache, sore throat, fever &  lack of appetite.  Most symptoms lasted approximately five days.  We were isolated for 10 days.
This spontaneous report as received from a 72 year old female patient refers to herself. On an unknown date the patient was vaccinated with ZOSTAVAX (lot#, expiration date, dose and frequency were unknown, route was reported as injection) for the prevention of shingles. On an unknown date the patient experienced injection site pain after receiving ZOSTAVAX. No treatment was given for the adverse event. The patient sought for medical attention by office visit on 29-OCT-2014. The outcome of injection site pain was reported as not recovered/not resolved. Additional information is not expected because no patient or physician's contact information was provided.
itchy rash with body aches, fevers, chills 1 week after vaccination Narrative:
pt recvd vax; 10-12 hrs later, devel fever up to 105 & also persistent crying lasting for 4-6 hrs;
Per patient report:  "The symptoms started the day after the shot, right when I woke up in the morning. The rash stayed for 5 ish days, the vomiting stayed around for 2. I was then at the beach and the rash seemed to worsen when I was in the sun so I stayed out of it for 3 more days and then everything calmed down"
I have had severe tonsillitis, sore throat, headache and fever since May 24.
chills; slight fever; aches; This case was reported by a consumer via interactive digital media and described the occurrence of chills in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced chills, fever and pain. On an unknown date, the outcome of the chills, fever and pain were unknown.   The reporter considered the chills, fever and pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient stated the first dose gave him/her a slight fever, chills and aches. The patient stated the second dose had no side effects and he/she would take the side effects compared to actually getting shingles, though. The patient stated he knew someone who got shingles in their eyes and it ruined their eyesight. The follow-up would not be possible as no contact details were available.
Pt received 2nd Covid-19 Pfizer vaccine on 02/26/2021. Pt noticed symptoms the next day 02/27/2021, swollen axillary glands to right and left side that are about half the size of a golf ball.. Pt stated that she called to inform her PCP of the symptoms. PCP advised pt on treatment for symptoms but PCP also informed pt to contact facility that administered the vaccine so that we can report the adverse effect accordingly.
Hi I received the J&J vaccine at pharmacy on March 10th and since then I have had a low grade fever that has not gone away.
This spontaneous report as received from a Licensed Practical Nurse refers to a 16 month old patient of unknown gender. No pertinent medical history, concurrent conditions, drug reactions, allergies or concomitant therapies were provided. On 05-JUL-2018, the patient was vaccinated with an improperly stored dose of PEDVAXHIB lot # R001085, expiration date on 30-SEP-2020, for prophylaxis (dosage schedule, route and anatomical location were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 0 to 1 (1.4) degrees Celsius for 3 hours. Digital Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1807USA004691: US-009507513-1807USA012290: US-009507513-1807USA012291: US-009507513-1807USA012292: US-009507513-1807USA012304: US-009507513-1807USA012294: US-009507513-1807USA012294: US-009507513-1807USA012296: US-009507513-1807USA012297: US-009507513-1807USA012298: US-009507513-1807USA012299: US-009507513-1807USA012300: US-009507513-1807USA012301: US-009507513-1807USA012302: US-009507513-1807USA012289: US-009507513-1807USA012288: US-009507513-1807USA012287: US-009507513-1807USA012286: US-009507513-1807USA012293.
Information has been received from a physician concerning a 2 year old female who was vaccinated SC with the first 0.5ml dose of varicella virus vaccine live at age one. Subsequently, the patient broke out with a rash and did not have a fever. Medical attention was sought and the doctor diagnosed the patient with Zoster. No treatment was given and the rash was reported to have lasted three days. No product quality complaint was involved. Additional information has been requested.